|
Real-time Estimate
Cboe BZX
20:41:36 11/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.38 USD | +1.52% |
|
-4.02% | -28.39% |
| Market Cap | 1.64B 1.47B 1.36B 1.23B 2.33B 154B 2.4B 16.23B 6.47B 82.39B 6.16B 6.02B 260B | P/E 2026 * |
-5.49x | P/E 2027 * | 34.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.12B 1.01B 929M 844M 1.6B 105B 1.64B 11.12B 4.43B 56.46B 4.22B 4.13B 178B | EV / Sales 2026 * |
1.48x | EV / Sales 2027 * | 0.95x |
| Free-Float |
96.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RARE | Delayed | |
CBOE
| RARE | Real-time | |
|
Tradegate
| UP0 | Real-time | |
|
Berne S.E.
| UP0 | End-of-day quote | |
|
Mexican S.E.
| RARE * | End-of-day quote | |
|
Deutsche Boerse AG
| UP0 | Delayed | |
|
Börse Stuttgart
| UP0 | Delayed | |
|
Boerse Muenchen
| UP0 | Real-time | |
|
Xetra
| UP0 | Delayed |
Last Transcript: Ultragenyx Pharmaceutical Inc.
| 1 day | +1.36% | ||
| 1 week | -4.02% | ||
| Current month | +2.30% | ||
| 1 month | +7.65% | ||
| 3 months | -38.91% | ||
| 6 months | -37.38% | ||
| Current year | -28.39% |
| 1 week | 15.12 |  | 17.12 |
| 1 month | 14.44 | | 17.67 |
| Current year | 12.73 | | 36.57 |
| 1 year | 12.73 | | 39.89 |
| 3 years | 12.73 | | 60.37 |
| 5 years | 12.73 | | 88.22 |
| 10 years | 12.73 | | 179.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emil Kakkis
CEO | Chief Executive Officer | 65 | 22/04/2010 |
Howard Horn
DFI | Director of Finance/CFO | 49 | 16/10/2023 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Kakkis
BRD | Director/Board Member | 65 | 22/04/2010 |
Matthew Fust
BRD | Director/Board Member | 62 | 01/01/2014 |
Michael Narachi
BRD | Director/Board Member | 66 | 20/02/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/10/26 | Sell | Chief Financial Officer | -7,066 | 0.0072% | ||
| 15/09/26 | Sell | Controller/Auditor | -1,283 | 0.0013% | ||
| 03/09/26 | Sell | Controller/Auditor | -161 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -4.02% | -50.47% | -53.36% | 1.64B | |
| -0.70% | +0.52% | +44.18% | +132.64% | 1,276B | |
| -1.10% | +0.61% | +43.42% | +88.31% | 676B | |
| -1.00% | -1.31% | +29.22% | +109.87% | 519B | |
| -0.17% | +1.31% | +38.93% | +68.00% | 388B | |
| -1.36% | -2.74% | +60.80% | +42.72% | 365B | |
| -1.16% | -1.00% | +27.71% | +57.08% | 307B | |
| -0.06% | -1.00% | +3.10% | +35.48% | 287B | |
| -0.74% | -3.25% | +36.79% | +73.59% | 252B | |
| -0.96% | -2.58% | +38.69% | +126.85% | 212B | |
| Average | -0.59% | +1.81% | +27.24% | +68.12% | 428B | |
| Weighted average by Cap. | -0.81% | +2.51% | +38.51% | +93.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 759M 680M 627M 569M 1.08B 71.12B 1.11B 7.51B 2.99B 38.1B 2.85B 2.79B 120B | 979M 878M 809M 735M 1.39B 91.78B 1.43B 9.69B 3.86B 49.17B 3.67B 3.6B 155B |
| Net income | -294M -264M -243M -221M -417M -27.55B -429M -2.91B -1.16B -14.76B -1.1B -1.08B -46.66B | 55.55M 49.81M 45.91M 41.69M 78.91M 5.21B 81.11M 550M 219M 2.79B 208M 204M 8.82B |
| Net Debt | -516M -463M -427M -388M -733M -48.41B -754M -5.11B -2.04B -25.94B -1.94B -1.9B -81.99B | -712M -639M -588M -534M -1.01B -66.76B -1.04B -7.05B -2.81B -35.77B -2.67B -2.62B -113B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | $16.47 | +2.04% | 404,673 |
| 10/11/26 | $16.14 | -1.65% | 5,464,849 |
| 09/11/26 | $16.41 | +6.35% | 2,669,211 |
| 06/11/26 | $15.43 | -0.90% | 4,049,187 |
| 05/11/26 | $15.57 | -9.27% | 5,390,974 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RARE Stock
Select your edition
All financial news and data tailored to specific country editions
